nitazoxanide has been researched along with Colonic Neoplasms in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Correia-Branco, A; Duarte, D; Martel, F; Patrício, B; Vale, N | 1 |
Sun, X; Yang, K; Yu, J; Zhao, W; Zheng, J | 1 |
Abd El-Fadeal, NM; Alomar, SY; Aloyouni, SY; El-Dosoky, M; El-Mistekawy, A; Elbahaie, AM; Hashish, AA; K El-Kherbetawy, M; Mohammad, HMF; Morsy, KM; Nafie, MS; Zaitone, SA | 1 |
Brokstad, KA; Cheng, PF; Hoffman, PS; Kalland, KH; Ke, X; Levesque, MP; Olsen, JR; Oyan, AM; Qu, Y; Yuan, X; Zhang, W | 1 |
4 other study(ies) available for nitazoxanide and Colonic Neoplasms
Article | Year |
---|---|
In vitro studies on the inhibition of colon cancer by amino acid derivatives of bromothiazole.
Topics: Amino Acids; Antineoplastic Agents; Apoptosis; Caco-2 Cells; Cell Proliferation; Colon; Colonic Neoplasms; Halogenation; Humans; Thiazoles | 2017 |
Synergistic tumor inhibition of colon cancer cells by nitazoxanide and obeticholic acid, a farnesoid X receptor ligand.
Topics: Animals; beta Catenin; Carcinogenesis; Cell Proliferation; Chenodeoxycholic Acid; Colonic Neoplasms; Drug Synergism; Gene Expression Regulation, Neoplastic; HCT116 Cells; Heterografts; Humans; Ligands; Liver; Mice; Molecular Targeted Therapy; Nitro Compounds; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Thiazoles | 2021 |
Antitumor Activity of Nitazoxanide against Colon Cancers: Molecular Docking and Experimental Studies Based on Wnt/β-Catenin Signaling Inhibition.
Topics: Animals; Antiparasitic Agents; Apoptosis; beta Catenin; Colonic Neoplasms; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3 beta; HCT116 Cells; Humans; Male; Mice; Molecular Docking Simulation; Nitro Compounds; Proliferating Cell Nuclear Antigen; Thiazoles; Wnt Signaling Pathway; Xenograft Model Antitumor Assays | 2021 |
Small molecule promotes β-catenin citrullination and inhibits Wnt signaling in cancer.
Topics: Animals; Antineoplastic Agents; beta Catenin; Cell Line, Tumor; Citrullination; Colonic Neoplasms; Gene Knockout Techniques; Humans; Nitro Compounds; Protein-Arginine Deiminase Type 2; Protein-Arginine Deiminases; Thiazoles; Wnt Signaling Pathway | 2018 |